|Articles|October 19, 2009
Emerging Pharma Leadership Awards - Michelle Dipp
Advertisement
Michelle Dipp,
VP & Head of US Center of Excellence for External Drug Discovery,
GlaxoSmithKline
Download Adobe Flash Player
“The current economic environment is forcing the industry to adapt and change for the better in order to survive. I believe this will result in survival of the fittest, and biotech will be a source of pride and innovation in the US for decades to come.”Listen to the Podcast for more coverage.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Why High-Risk Patients Still Need Antivirals: Q&A with Gurinder S. Sidhu, M.D.
2
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
3
A Patent Strategy Pharma Execs May Be Overlooking: Means-Plus-Function Claims
4
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
5